Pancoast tumor epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pancoast tumor}} | {{Pancoast tumor}} | ||
{{CMG}}{{AE}}{{Mazia}} | {{CMG}}; {{AE}} {{Mazia}} | ||
==Overveiw== | ==Overveiw== | ||
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers. In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000 | Pancoast tumors are a rare type of [[Non-small cell lung cancer|non-small cell lung cancers]] ([[NSCLC]]), account for fewer than 5% of all [[lung]] [[cancers]]. In the United States, the age-adjusted [[prevalence]] of pancoast tumor is estimated to be 5 per 100,000. In 2014, the [[incidence]] of Pancoast tumor was approximately 3 per 100,000 individuals. It is [[rare]] in people under age 45. [[Males]] are thought to be more predisposed to the [[development]] of [[lung cancer]]. The [[male]] to [[female]] [[ratio]] for the [[incidence]] of [[lung]] [[cancer]] is approximately 1.4 to 1. There is no [[racial]] predilection for Pancoast tumor. The [[incidence]] of [[lung]] [[cancer]] is lower in developing countries than in developed countries. Western Europe and the U.S. have the highest [[incidence]] of [[lung]] [[cancer]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.<ref name=SEER>Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref name="SiegelMa2014">{{cite journal|last1=Siegel|first1=Rebecca|last2=Ma|first2=Jiemin|last3=Zou|first3=Zhaohui|last4=Jemal|first4=Ahmedin|title=Cancer statistics, 2014|journal=CA: A Cancer Journal for Clinicians|volume=64|issue=1|year=2014|pages=9–29|issn=00079235|doi=10.3322/caac.21208 | Pancoast tumors are a [[rare]] type of [[Non-small cell lung cancer|non-small cell lung cancers]] ([[NSCLC]]), account for fewer than 5% of all [[lung]] [[cancers]].<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref name="SiegelMa2014">{{cite journal|last1=Siegel|first1=Rebecca|last2=Ma|first2=Jiemin|last3=Zou|first3=Zhaohui|last4=Jemal|first4=Ahmedin|title=Cancer statistics, 2014|journal=CA: A Cancer Journal for Clinicians|volume=64|issue=1|year=2014|pages=9–29|issn=00079235|doi=10.3322/caac.21208}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000. | *In the United States, the age-adjusted [[prevalence]] of pancoast tumor is estimated to be 5 per 100,000 individuals.<ref name="pmid8010786">{{cite journal |vauthors=Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB |title=Influence of surgical resection and brachytherapy in the management of superior sulcus tumor |journal=Ann. Thorac. Surg. |volume=57 |issue=6 |pages=1440–5 |date=June 1994 |pmid=8010786 |doi= |url= |author=}}</ref><ref name=":0">{{cite web | title =Gender in lung cancer and smoking research | publisher =World Health Organization | date =2004 | url =http://www.who.int/gender/documents/en/lungcancerlow.pdf| format = PDF | accessdate =2007-05-26 }}</ref> | ||
*The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer. | *The [[prevalence]] of [[lung]] [[cancer]] significantly increases among [[Smoker's cough|smokers]] and individuals with [[chronic]] exposure to [[risk factors]] for [[lung cancer]]. | ||
===Incidence=== | ===Incidence=== | ||
*In 2014 the incidence of Pancoast tumor was approximately 3 | *In 2014, the [[incidence]] of Pancoast tumor was approximately 3 per 100,000 individuals.<ref name="pmid8010786" /><ref name=":0" /> | ||
*According to the American Cancer Society, an estimated 3,000 nonsmoking adults will die each year from lung cancer related to breathing secondhand smoke. | *According to the American Cancer Society, an estimated 3,000 nonsmoking [[Adult|adults]] will die each year from [[lung cancer]] related to [[breathing]] secondhand [[smoke]]. | ||
*Each year more people die of lung cancer than breast, colon, and prostate cancers combined. | *Each year more people die of [[lung cancer]] than [[breast]], [[colon]], and [[prostate]] [[cancers]] combined. | ||
*It is unclear whether the increased incidence of lung cancer is due to increased cancers or improved cancer detection (e.g. screening techniques) | *It is unclear whether the increased [[incidence]] of [[lung cancer]] is due to increased [[cancers]] or improved [[cancer]] detection (e.g. [[Screening (medicine)|screening]] techniques). | ||
===Age=== | ===Age=== | ||
*Lung cancer is more common in older | *[[Lung cancer]] is more common in older people. It is rare in people under age 45.<ref name="pmid9189936">{{cite journal |vauthors=Johnson DE, Goldberg M |title=Management of carcinoma of the superior pulmonary sulcus |journal=Oncology (Williston Park, N.Y.) |volume=11 |issue=6 |pages=781–5; discussion 785–6 |date=June 1997 |pmid=9189936 |doi= |url= |author=}}</ref> | ||
===Gender=== | ===Gender=== | ||
*Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females. | *[[Males]] are thought to be more predisposed to the development of [[lung cancer]]. This gender discrepancy is often attributed to the historically increased [[rate]] of [[smoking]] among [[males]] compared to [[females]].<ref name=":0" /> | ||
*The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1. | *The [[male]] to [[female]] [[ratio]] for the [[incidence]] of [[lung]] [[cancer]] is approximately 1.4 to 1. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection for Pancoast tumor. | *There is no [[racial]] predilection for Pancoast tumor.<ref name=":0" /> | ||
===Developing Countries=== | ===Developing Countries=== | ||
*The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates. | *The [[incidence]] of [[lung cancer]] is lower in developing countries than in developed countries. It is unknown whether this decreased [[incidence]] is due to decreased [[cancer]] rates or decreased detection rates.<ref name="pmid9189936" /> | ||
===Developed Countries=== | ===Developed Countries=== | ||
*Western Europe and the U.S. have the highest incidence of lung cancer. | *Western Europe and the U.S. have the highest [[incidence]] of [[lung cancer]].<ref name="pmid8010786" /> | ||
==References== | ==References== | ||
Latest revision as of 20:51, 27 March 2018
|
Pancoast tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancoast tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pancoast tumor epidemiology and demographics |
|
Risk calculators and risk factors for Pancoast tumor epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overveiw
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers. In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000. In 2014, the incidence of Pancoast tumor was approximately 3 per 100,000 individuals. It is rare in people under age 45. Males are thought to be more predisposed to the development of lung cancer. The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1. There is no racial predilection for Pancoast tumor. The incidence of lung cancer is lower in developing countries than in developed countries. Western Europe and the U.S. have the highest incidence of lung cancer.
Epidemiology and Demographics
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.[1][2]
Prevalence
- In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000 individuals.[3][4]
- The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer.
Incidence
- In 2014, the incidence of Pancoast tumor was approximately 3 per 100,000 individuals.[3][4]
- According to the American Cancer Society, an estimated 3,000 nonsmoking adults will die each year from lung cancer related to breathing secondhand smoke.
- Each year more people die of lung cancer than breast, colon, and prostate cancers combined.
- It is unclear whether the increased incidence of lung cancer is due to increased cancers or improved cancer detection (e.g. screening techniques).
Age
- Lung cancer is more common in older people. It is rare in people under age 45.[5]
Gender
- Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females.[4]
- The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1.
Race
Developing Countries
- The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.[5]
Developed Countries
- Western Europe and the U.S. have the highest incidence of lung cancer.[3]
References
- ↑ Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
- ↑ Siegel, Rebecca; Ma, Jiemin; Zou, Zhaohui; Jemal, Ahmedin (2014). "Cancer statistics, 2014". CA: A Cancer Journal for Clinicians. 64 (1): 9–29. doi:10.3322/caac.21208. ISSN 0007-9235.
- ↑ 3.0 3.1 3.2 Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB (June 1994). "Influence of surgical resection and brachytherapy in the management of superior sulcus tumor". Ann. Thorac. Surg. 57 (6): 1440–5. PMID 8010786.
- ↑ 4.0 4.1 4.2 4.3 "Gender in lung cancer and smoking research" (PDF). World Health Organization. 2004. Retrieved 2007-05-26.
- ↑ 5.0 5.1 Johnson DE, Goldberg M (June 1997). "Management of carcinoma of the superior pulmonary sulcus". Oncology (Williston Park, N.Y.). 11 (6): 781–5, discussion 785–6. PMID 9189936.